NCT06264193

Brief Summary

The response to hypoxia is very individual and depending on many aspects, such as the type of training, duration, intensity, or hypoxic stimulus, hypoxia affects the athlete in various ways. This multi-stage study investigated hematological and physiological responses to normobaric Live High-Train Low (LHTL) exposure in elite male rowers from the Polish national rowing team. Stage I evaluated responses during an 18-day LHTL intervention, whereas Stage II evaluated responses during a 14-day LHTL intervention and extended the assessment to 42 days after return to normoxia. The study focused particularly on hematological variables, erythropoietin (EPO), vascular endothelial growth factor (VEGF), and other physiological and biochemical responses associated with hypoxic exposure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2015

Completed
8.1 years until next milestone

First Submitted

Initial submission to the registry

January 10, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 16, 2024

Completed
Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

1.1 years

First QC Date

January 10, 2024

Last Update Submit

September 15, 2026

Conditions

Keywords

hypoxiarowersexerciseEPOathletesLH-TLhematological adaptationelite athletes

Outcome Measures

Primary Outcomes (2)

  • Erythropoietin (EPO) mlU/ml

    immunoenzymatic assay methods using diagnostic kits

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

  • Vascular endothelial growth factor (VEGF) mlU/ml

    immunoenzymatic assay methods using diagnostic kits

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

Secondary Outcomes (9)

  • Creatine kinase (CK) ng/ml

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

  • Hs C-Reactive Protein (hsCRP) mg/L

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention.

  • Hemoglobin (Hb)g/dL

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

  • Hematocrit (Htc)%

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

  • Red blood cells (RBC)mln/mm3

    Stage 1: at baseline and on days 6, 12, and 18 of the intervention. Stage 2: at baseline, on days 7 and 14 of the intervention, and at 8, 14, and 42 days after the intervention.

  • +4 more secondary outcomes

Other Outcomes (5)

  • Body mass (kg)

    Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.

  • Body fat percentage (%)

    Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.

  • Fat mass (kg)

    Stage 1: baseline and Days 6, 12, and 18 of the intervention; Stage 2: baseline and Days 7 and 14 of the intervention, and 8, 14, and 42 days after the intervention.

  • +2 more other outcomes

Study Arms (2)

LHTL

EXPERIMENTAL

Participants assigned to the LHTL group underwent their regular sports training while living in normobaric hypoxic rooms.

Other: Normobaric hypoxia (LHTL)

Control group

NO INTERVENTION

Participants assigned to the control group completed the same sports training as the LHTL group while living in normoxic conditions at the same training camp.

Interventions

Participants lived in normobaric hypoxic rooms for 14-16 h per day while completing their regular training under normoxic conditions. The simulated altitude was progressively increased during the intervention.

LHTL

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male national-team rowers aged ≥18 years.
  • Regular participation in rowing training.
  • Participation in the training camp.

You may not qualify if:

  • Exposure to hypoxic conditions or altitude above 1500 m within 1 month before the study.
  • Medical contraindications or adverse symptoms associated with hypoxic exposure.
  • Injury or health condition preventing participation in the training program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Kasperska A, Zembron-Lacny A. The effect of intermittent hypoxic exposure on erythropoietic response and hematological variables in elite athletes. Physiol Res. 2020 Apr 30;69(2):283-290. doi: 10.33549/physiolres.934316. Epub 2020 Mar 23.

    PMID: 32199016BACKGROUND
  • Wilber RL. Application of altitude/hypoxic training by elite athletes. Med Sci Sports Exerc. 2007 Sep;39(9):1610-24. doi: 10.1249/mss.0b013e3180de49e6.

    PMID: 17805095BACKGROUND
  • Czuba M, Fidos-Czuba O, Ploszczyca K, Zajac A, Langfort J. Comparison of the effect of intermittent hypoxic training vs. the live high, train low strategy on aerobic capacity and sports performance in cyclists in normoxia. Biol Sport. 2018 Mar;35(1):39-48. doi: 10.5114/biolsport.2018.70750. Epub 2017 Oct 11.

  • Ploszczyca K, Langfort J, Czuba M. The Effects of Altitude Training on Erythropoietic Response and Hematological Variables in Adult Athletes: A Narrative Review. Front Physiol. 2018 Apr 11;9:375. doi: 10.3389/fphys.2018.00375. eCollection 2018.

  • Kasperska A, Dziewiecka H, Jankowski W, Mikulski T, Czerniec I, Skarpanska-Stejnborn A, Ostapiuk-Karolczuk J. Hematological, inflammatory, and hypoxia-responsive adaptations to 18-day normobaric live high-train low training in elite rowers. Front Physiol. 2026 May 13;17:1834329. doi: 10.3389/fphys.2026.1834329. eCollection 2026.

Related Links

MeSH Terms

Conditions

HypoxiaMotor Activity

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Anna Kasperska

    Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland;

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants were randomly assigned to one of two parallel groups: a hypoxic Live High-Train Low (LHTL) group, which underwent the same sports training while living in normobaric hypoxic conditions, and a control (CON) group, which completed the same training while living in normoxic conditions.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants were assigned to two parallel groups: an LHTL group, which completed the same sports training while living in normobaric hypoxic conditions, and a control group, which completed the same training while living in normoxic conditions. The hypoxic exposure protocol differed between Stage I and Stage II as described in the study protocol.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2024

First Posted

February 16, 2024

Study Start

November 30, 2014

Primary Completion

December 21, 2015

Study Completion

December 21, 2015

Last Updated

September 21, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to participant confidentiality and data protection considerations.